Stanford researchers introduced affordable gene-editing kits ready for the classroom, aiming to make the field more accessible for high school students.

Beans are a key food at the dietary level, boasting high nutritional value and constituting the most directly consumed legume ...

Financial writer recommends Crispr Therapeutics AG as a strong buy due to cash position, drug pipeline, and promising ...

Fintel reports that on February 3, 2025, HC Wainwright & Co. initiated coverage of CRISPR Therapeutics (NasdaqGM:CRSP) with a ...

We recently compiled a list of the Cathie Wood’s Stock Portfolio: 2025 Stock Picks. In this article, we are going to take a look at where CRISPR Therapeutics AG (NASDAQ:CRSP) stands against the other ...

ZUG, Switzerland and BOSTON, Jan. 29, 2025 (GLOBE NEWSWIRE) -- CRISPR Therapeutics (Nasdaq: CRSP), a biopharmaceutical company focused on creating transformative gene-based medicines for serious ...

The NIH said Friday night that it would slash support for indirect costs on all existing and future grants to 15% ...

Prime Medicine, Inc. faces risks in the gene editing sector despite positive developments, caution advised for retail investors. Click for my PRME stock update.

The first-ever CRISPR-based gene-editing therapy has been ... Availability will depend on an appraisal of the therapy’s cost-effectiveness, and Casgevy's price is expected to be upwards of ...

Imagine breaking your ankle but not being able to get the right amount of emergency care due to the cost. That doesn’t sound great. But, believe it or not, this situation happens to some people.

CNBC Select will update as changes are made public. With a high-yield savings account, you can get a solid interest rate and your money grows even faster thanks to compound interest — which lets ...